{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:23:20Z","timestamp":1793064200599,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,6,14]],"date-time":"2009-06-14T00:00:00Z","timestamp":1244937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2009,6,14]],"date-time":"2009-06-14T00:00:00Z","timestamp":1244937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1038\/nm.1978","type":"journal-article","created":{"date-parts":[[2009,6,9]],"date-time":"2009-06-09T14:17:00Z","timestamp":1244557020000},"page":"781-787","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":559,"title":["A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis"],"prefix":"10.1038","volume":"15","author":[{"given":"Tony","family":"Muchamuel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Basler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monette A","family":"Aujay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid W","family":"Kalim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Sylvain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen R","family":"Ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Shwonek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Parlati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan D","family":"Demo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark K","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Groettrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,14]]},"reference":[{"key":"BFnm1978_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.med.50.1.57","volume":"50","author":"AL Schwartz","year":"1999","unstructured":"Schwartz, A.L. & Ciechanover, A. The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu. Rev. Med. 50, 57\u201374 (1999).","journal-title":"Annu. Rev. Med."},{"key":"BFnm1978_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/35056572","volume":"2","author":"PM Kloetzel","year":"2001","unstructured":"Kloetzel, P.M. Antigen processing by the proteasome. Nat. Rev. Mol. Cell Biol. 2, 179\u2013188 (2001).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnm1978_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1021\/cr0502504","volume":"107","author":"L Borissenko","year":"2007","unstructured":"Borissenko, L. & Groll, M. 20S proteasome and its inhibitors: crystallographic knowledge for drug development. Chem. Rev. 107, 687\u2013717 (2007).","journal-title":"Chem. Rev."},{"key":"BFnm1978_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.coi.2003.11.004","volume":"16","author":"PM Kloetzel","year":"2004","unstructured":"Kloetzel, P.M. & Ossendorp, F. Proteasome and peptidase function in MHC-class-I\u2013mediated antigen presentation. Curr. Opin. Immunol. 16, 76\u201381 (2004).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnm1978_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1084\/jem.187.1.97","volume":"187","author":"TA Griffin","year":"1998","unstructured":"Griffin, T.A. et al. Immunoproteasome assembly: cooperative incorporation of interferon \u03b3 (IFN-\u03b3)-inducible subunits. J. Exp. Med. 187, 97\u2013104 (1998).","journal-title":"J. Exp. Med."},{"key":"BFnm1978_CR6","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.4049\/jimmunol.173.6.3925","volume":"173","author":"M Basler","year":"2004","unstructured":"Basler, M., Youhnovski, N., van den Broek, M., Przybylski, M. & Groettrup, M. Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus. J. Immunol. 173, 3925\u20133934 (2004).","journal-title":"J. Immunol."},{"key":"BFnm1978_CR7","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.4049\/jimmunol.176.11.6665","volume":"176","author":"M Basler","year":"2006","unstructured":"Basler, M., Moebius, J., Elenich, L., Groettrup, M. & Monaco, J.J. An altered T cell repertoire in MECL-1\u2013deficient mice. J. Immunol. 176, 6665\u20136672 (2006).","journal-title":"J. Immunol."},{"key":"BFnm1978_CR8","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1084\/jem.193.11.1319","volume":"193","author":"W Chen","year":"2001","unstructured":"Chen, W., Norbury, C.C., Cho, Y., Yewdell, J.W. & Bennink, J.R. Immunoproteasomes shape immunodominance hierarchies of antiviral CD8+ T cells at the levels of T cell repertoire and presentation of viral antigens. J. Exp. Med. 193, 1319\u20131326 (2001).","journal-title":"J. Exp. Med."},{"key":"BFnm1978_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00109-003-0422-2","volume":"81","author":"PJ Elliott","year":"2003","unstructured":"Elliott, P.J., Zollner, T.M. & Boehncke, W.H. Proteasome inhibition: a new anti-inflammatory strategy. J. Mol. Med. 81, 235\u2013245 (2003).","journal-title":"J. Mol. Med."},{"key":"BFnm1978_CR10","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMoa043445","volume":"352","author":"PG Richardson","year":"2005","unstructured":"Richardson, P.G. et al. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N. Engl. J. Med. 352, 2487\u20132498 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1978_CR11","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.4049\/jimmunol.171.3.1515","volume":"171","author":"N Qureshi","year":"2003","unstructured":"Qureshi, N. et al. The proteasome as a lipopolysaccharide-binding protein in macrophages: differential effects of proteasome inhibition on lipopolysaccharide-induced signaling events. J. Immunol. 171, 1515\u20131525 (2003).","journal-title":"J. Immunol."},{"key":"BFnm1978_CR12","doi-asserted-by":"publisher","first-page":"15671","DOI":"10.1073\/pnas.95.26.15671","volume":"95","author":"VJ Palombella","year":"1998","unstructured":"Palombella, V.J. et al. Role of the proteasome and NF-\u03baB in streptococcal cell wall-induced polyarthritis. Proc. Natl. Acad. Sci. USA 95, 15671\u201315676 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1978_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth759","volume":"2","author":"CR Berkers","year":"2005","unstructured":"Berkers, C.R. et al. Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib. Nat. Methods 2, 357\u2013362 (2005).","journal-title":"Nat. Methods"},{"key":"BFnm1978_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ccr.2005.10.013","volume":"8","author":"D Chauhan","year":"2005","unstructured":"Chauhan, D. et al. A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from bortezomib. Cancer Cell 8, 407\u2013419 (2005).","journal-title":"Cancer Cell"},{"key":"BFnm1978_CR15","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1158\/0008-5472.CAN-06-4086","volume":"67","author":"SD Demo","year":"2007","unstructured":"Demo, S.D. et al. Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome. Cancer Res. 67, 6383\u20136391 (2007).","journal-title":"Cancer Res."},{"key":"BFnm1978_CR16","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1158\/1078-0432.CCR-03-0781","volume":"10","author":"PF Bross","year":"2004","unstructured":"Bross, P.F. et al. Approval summary for bortezomib for injection in the treatment of multiple myeloma. Clin. Cancer Res. 10, 3954\u20133964 (2004).","journal-title":"Clin. Cancer Res."},{"key":"BFnm1978_CR17","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1182\/blood-2007-01-065888","volume":"110","author":"DJ Kuhn","year":"2007","unstructured":"Kuhn, D.J. et al. Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma. Blood 110, 3281\u20133290 (2007).","journal-title":"Blood"},{"key":"BFnm1978_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/BF00184520","volume":"38","author":"E Zanelli","year":"1993","unstructured":"Zanelli, E., Zhou, P., Cao, H., Smart, M.K. & David, C.S. Genomic organization and tissue expression of the mouse proteasome gene Lmp-7. Immunogenetics 38, 400\u2013407 (1993).","journal-title":"Immunogenetics"},{"key":"BFnm1978_CR19","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1126\/science.8066463","volume":"265","author":"HJ Fehling","year":"1994","unstructured":"Fehling, H.J. et al. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265, 1234\u20131237 (1994).","journal-title":"Science"},{"key":"BFnm1978_CR20","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1074\/jbc.M209292200","volume":"278","author":"M De","year":"2003","unstructured":"De, M. et al. \u03b22 subunit propeptides influence cooperative proteasome assembly. J. Biol. Chem. 278, 6153\u20136159 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnm1978_CR21","doi-asserted-by":"publisher","first-page":"6859","DOI":"10.4049\/jimmunol.167.12.6859","volume":"167","author":"S Khan","year":"2001","unstructured":"Khan, S. et al. Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver. J. Immunol. 167, 6859\u20136868 (2001).","journal-title":"J. Immunol."},{"key":"BFnm1978_CR22","doi-asserted-by":"publisher","first-page":"9213","DOI":"10.1073\/pnas.91.20.9213","volume":"91","author":"M Gaczynska","year":"1994","unstructured":"Gaczynska, M., Rock, K.L., Spies, T. & Goldberg, A.L. Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. Proc. Natl. Acad. Sci. USA 91, 9213\u20139217 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1978_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.chembiol.2007.03.008","volume":"14","author":"YK Ho","year":"2007","unstructured":"Ho, Y.K., Bargagna-Mohan, P., Wehenkel, M., Mohan, R. & Kim, K.B. LMP2-specific inhibitors: chemical genetic tools for proteasome biology. Chem. Biol. 14, 419\u2013430 (2007).","journal-title":"Chem. Biol."},{"key":"BFnm1978_CR24","doi-asserted-by":"publisher","first-page":"983","DOI":"10.4049\/jimmunol.177.2.983","volume":"177","author":"MJ Palmowski","year":"2006","unstructured":"Palmowski, M.J. et al. Role of immunoproteasomes in cross-presentation. J. Immunol. 177, 983\u2013990 (2006).","journal-title":"J. Immunol."},{"key":"BFnm1978_CR25","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.4049\/jimmunol.175.2.1153","volume":"175","author":"AK Nussbaum","year":"2005","unstructured":"Nussbaum, A.K., Rodriguez-Carreno, M.P., Benning, N., Botten, J. & Whitton, J.L. Immunoproteasome-deficient mice mount largely normal CD8+ T cell responses to lymphocytic choriomeningitis virus infection and DNA vaccination. J. Immunol. 175, 1153\u20131160 (2005).","journal-title":"J. Immunol."},{"key":"BFnm1978_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0092-8674(91)90164-T","volume":"65","author":"PS Ohashi","year":"1991","unstructured":"Ohashi, P.S. et al. Ablation of 'tolerance' and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65, 305\u2013317 (1991).","journal-title":"Cell"},{"key":"BFnm1978_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/342559a0","volume":"342","author":"H Pircher","year":"1989","unstructured":"Pircher, H., Burki, K., Lang, R., Hengartner, H. & Zinkernagel, R.M. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342, 559\u2013561 (1989).","journal-title":"Nature"},{"key":"BFnm1978_CR28","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.4049\/jimmunol.176.7.4075","volume":"176","author":"CM Caudill","year":"2006","unstructured":"Caudill, C.M. et al. T cells lacking immunoproteasome subunits MECL-1 and LMP7 hyperproliferate in response to polyclonal mitogens. J. Immunol. 176, 4075\u20134082 (2006).","journal-title":"J. Immunol."},{"key":"BFnm1978_CR29","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.4049\/jimmunol.169.3.1459","volume":"169","author":"T Kagari","year":"2002","unstructured":"Kagari, T., Doi, H. & Shimozato, T. The importance of IL-1 \u03b2 and TNF-\u03b1, and the noninvolvement of IL-6, in the development of monoclonal antibody\u2013induced arthritis. J. Immunol. 169, 1459\u20131466 (2002).","journal-title":"J. Immunol."},{"key":"BFnm1978_CR30","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/1074-7613(94)90043-4","volume":"1","author":"L Van Kaer","year":"1994","unstructured":"Van Kaer, L. et al. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1, 533\u2013541 (1994).","journal-title":"Immunity"},{"key":"BFnm1978_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jmb.2007.07.038","volume":"373","author":"N Klare","year":"2007","unstructured":"Klare, N., Seeger, M., Janek, K., Jungblut, P.R. & Dahlmann, B. Intermediate-type 20 S proteasomes in HeLa cells: 'asymmetric' subunit composition, diversity and adaptation. J. Mol. Biol. 373, 1\u201310 (2007).","journal-title":"J. Mol. Biol."},{"key":"BFnm1978_CR32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jneuroim.2007.09.024","volume":"192","author":"RF Frausto","year":"2007","unstructured":"Frausto, R.F., Crocker, S.J., Eam, B., Whitmire, J.K. & Whitton, J.L. Myelin oligodendrocyte glycoprotein peptide\u2013induced experimental allergic encephalomyelitis and T cell responses are unaffected by immunoproteasome deficiency. J. Neuroimmunol. 192, 124\u2013133 (2007).","journal-title":"J. Neuroimmunol."},{"key":"BFnm1978_CR33","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1365-2567.2006.02487.x","volume":"120","author":"C Naujokat","year":"2007","unstructured":"Naujokat, C. et al. Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells. Immunology 120, 120\u2013132 (2007).","journal-title":"Immunology"},{"key":"BFnm1978_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1385\/IR:31:3:243","volume":"31","author":"N Qureshi","year":"2005","unstructured":"Qureshi, N. et al. The proteasome: a central regulator of inflammation and macrophage function. Immunol. Res. 31, 243\u2013260 (2005).","journal-title":"Immunol. Res."},{"key":"BFnm1978_CR35","doi-asserted-by":"publisher","first-page":"8582","DOI":"10.1074\/jbc.M509043200","volume":"281","author":"AF Kisselev","year":"2006","unstructured":"Kisselev, A.F., Callard, A. & Goldberg, A.L. Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate. J. Biol. Chem. 281, 8582\u20138590 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnm1978_CR36","doi-asserted-by":"publisher","first-page":"6238","DOI":"10.4049\/jimmunol.177.9.6238","volume":"177","author":"B Strehl","year":"2006","unstructured":"Strehl, B. et al. Immunoproteasomes are essential for clearance of Listeria monocytogenes in nonlymphoid tissues but not for induction of bacteria-specific CD8+ T cells. J. Immunol. 177, 6238\u20136244 (2006).","journal-title":"J. Immunol."},{"key":"BFnm1978_CR37","doi-asserted-by":"publisher","first-page":"7240","DOI":"10.4049\/jimmunol.165.12.7240","volume":"165","author":"RO Williams","year":"2000","unstructured":"Williams, R.O., Marinova-Mutafchieva, L., Feldmann, M. & Maini, R.N. Evaluation of TNF-\u03b1 and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-\u03b1\/anti-CD4 therapy. J. Immunol. 165, 7240\u20137245 (2000).","journal-title":"J. Immunol."},{"key":"BFnm1978_CR38","volume-title":"Compounds For Enzyme Inhibition","author":"KD Shenk","year":"2008","unstructured":"Shenk, K.D. et al. Compounds For Enzyme Inhibition. US Patent 2007\/0293465 A1, (2008)."},{"key":"BFnm1978_CR39","doi-asserted-by":"publisher","first-page":"23808","DOI":"10.1074\/jbc.270.40.23808","volume":"270","author":"M Groettrup","year":"1995","unstructured":"Groettrup, M. et al. The interferon-\u03b3-inducible 11 S regulator (PA28) and the LMP2\/LMP7 subunits govern the peptide production by the 20 S proteasome in vitro. J. Biol. Chem. 270, 23808\u201323815 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnm1978_CR40","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/eji.200636372","volume":"37","author":"M Basler","year":"2007","unstructured":"Basler, M. & Groettrup, M. No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes. Eur. J. Immunol. 37, 896\u2013904 (2007).","journal-title":"Eur. J. Immunol."}],"updated-by":[{"DOI":"10.1038\/nm1109-1333a","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000}}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nm.1978.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm.1978","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm.1978.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T04:37:17Z","timestamp":1744346237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.1978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,14]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["BFnm1978"],"URL":"https:\/\/doi.org\/10.1038\/nm.1978","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1164429.626177","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,14]]},"assertion":[{"value":"17 February 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2009","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of this article initially published, the structure of PR-957 in Figure 1a was incorrect. An -NH group was missing. The error has been corrected in the HTML and PDF versions of the article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.M., M.A.A., E.S., C.S., E.R.R., J.S., J.J., P.S., F.P., S.D.D., M.K.B. and C.J.K. are or were employees of Proteolix, Inc. and hold options for or actual shares of ownership of Proteolix, Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}